TY - EJOU AU - Pan, Yongsheng AU - Liu, Bo AU - Xu, Siyang AU - Jiang, Jie AU - Chen, Zhan AU - Wang, Lin AU - Wang, Tianle AU - Xue, Wei AU - Zhu, Hua AU - Zheng, Bing TI - Efficacy analysis and learning curve of holmium laser enucleation of the prostate with the en-bloc technique by a junior surgeon T2 - Canadian Journal of Urology PY - VL - IS - SN - 1488-5581 AB - Backgrounds: Holmium laser enucleation of the prostate (HoLEP) is recommended as a surgical option for benign prostatic hyperplasia (BPH), but its steep learning curve hinders clinical adoption and widespread use. Objective: This study aims to analyze the efficacy, safety, and learning curve of en-bloc HoLEP performed by a junior surgeon across 61 consecutive cases. Methods: A retrospective analysis was conducted on 61 consecutive BPH patients who underwent en-bloc HoLEP performed by a junior surgeon at our center between June and December 2024. Enucleation efficiency was defined as enucleation weight divided by enucleation time. Cumulative sum (CUSUM) analysis was adopted to stratify learning stages based on slope changes of the CUSUM curve, and Locally Estimated Scatterplot Smoothing (LOESS) was used for visualizing the overall trend of enucleation efficiency. The learning process was categorized into three stages: initial (cases 1–20), transitional (cases 21–40), and proficient (cases 41–61). The three groups were compared regarding baseline characteristics, perioperative parameters, complications, and six-month postoperative outcomes. Results: All 61 procedures were completed successfully without conversion to open surgery or transurethral resection of the prostate (TURP). Enucleation efficiency improved significantly across the three stages (0.71 ± 0.19 vs. 1.00 ± 0.22 vs. 1.28 ± 0.37 g/min, p < 0.001). Prostate volume was significantly larger in the proficient stage (93.54 ± 30.61 mL) than in the initial (67.72 ± 11.26 mL) and transitional (71.90 ± 18.29 mL) stages (both p < 0.05). Perioperative complication rates were comparable across the three groups (p > 0.05). At the 6-month follow-up, no significant inter-stage differences were observed in International Prostate Symptom Score (IPSS), post-void residual volume (PVR), or peak urinary flow rate (Qmax) among the three groups (p > 0.05), though all parameters had significantly improved relative to preoperative baseline values (p < 0.05). Conclusions: En-bloc HoLEP is safe and effective for BPH. A junior surgeon can preliminarily master this technique after approximately 20 cases, and enter a phase of rapid efficiency improvement after 40 consecutive cases. KW - holmium laser enucleation of the prostate; en-bloc; benign prostatic hyperplasia; learning curve; junior surgeon DO - 10.32604/cju.2026.084223